Paola Valente
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Paola Valente has a total of 62 co-authors. Here are the top co-authors by number of shared publications:
- Antonino Romanzo
Ophthalmology Unit, Bambino Gesù Children’s Hospital, IRCCS, 00165 Rome, Italy
4 shared publications - Luca Buzzonetti
Ophthalmology Unit, Bambino Gesù Children's Hospital, Rome, Italy, Italy
4 shared publications - Raffaele Cozza
Pediatric Oncology Unit, Ospedale Pediatrico Bambino Gesù, Rome, Italy
4 shared publications - Adriano Angioni
Laboratory of Medical Genetics Unit, “Bambino Gesù” Children’s Hospital, IRCCS, Viale di San Paolo 15, 00146 Rome, Italy
3 shared publications - Giancarlo Iarossi
Ophthalmology Unit, Bambino Gesù Children's Hospital, Rome, Italy, Italy
3 shared publications - Maria Antonietta De Ioris
Paediatric Haematology and Oncology, Cell and Gene Therapy, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy
3 shared publications
Latest Publications
- Open Access
- 4 November 2026
- Published by MDPI AG in Preprints.org
Association Between Pupil Dynamics and Peripheral Defocus Spectacle Lens Effectiveness in Slowing Myopia Progression in European Caucasian Pediatric Patients. Preliminary Study
Background: To evaluate whether pupil dynamics affect the effectiveness of peripheral defocus spectacle lenses in slowing myopia progression in European Caucasian pediatric patients. Methods: This non-randomized retrospective observational study included 53 children (mean age 10±3 years) with documented progressive myopia and no ocular disease. We retrospectively reviewed the records of patients who had worn Defocus Incorporated Multiple Segments (DIMS; Hoya MiyoSmart, group A) or Highly Aspherical Lenslet Target (HALT; Stellest; EssilorLuxottica, group B) spectacle lens for at least 24 months. Cycloplegic spherical equivalent (SE) and axial length (AL), were measured at baseline and at 24 month follow- up, and myopia progression was calculated as the difference between mean SE and AL during the follow-up time. Dynamic pupillometry was measured once during the follow-up and the pupil diameter change (PDC) was calculated as the millimeters difference between scotopic and photopic diameter. Results: After 24 months, group A and B did not differ significantly in SE, AL and PDC change (p > 0.05). In group A and B the SE change was positively correlated with PDC (p < 0.05), while AL change and PDC did not show significant correlation in both groups (p > 0.05). For group A and B the PDC median was respectively 4.5 and 4.7mm.Conclusion: These findings suggest that AL change could be considered not dependent by pupil dynamics for evaluating myopia progression, and that a PDC lower than 4.5mm seems to improve the effectiveness of peripheral defocus spectacle lenses in slowing SE increase in European Caucasian pediatric patients, without significant differences between DIMS and HALT design.
- 4 November 2026
- Published by MDPI AG in Preprints.org
Open AccessAssociation Between Pupil Dynamics and Peripheral Defocus Spectacle Lens Effectiveness in Slowing Myopia Progression in European Caucasian Pediatric Patients. Preliminary Study
Background: To evaluate whether pupil dynamics affect the effectiveness of peripheral defocus spectacle lenses in slowing myopia progression in European Caucasian pediatric patients. Methods: This non-randomized retrospective observational study included 53 children (mean age 10±3 years) with documented progressive myopia and no ocular disease. We retrospectively reviewed the records of patients who had worn Defocus Incorporated Multiple Segments (DIMS; Hoya MiyoSmart, group A) or Highly Aspherical Lenslet Target (HALT; Stellest; EssilorLuxottica, group B) spectacle lens for at least 24 months. Cycloplegic spherical equivalent (SE) and axial length (AL), were measured at baseline and at 24 month follow- up, and myopia progression was calculated as the difference between mean SE and AL during the follow-up time. Dynamic pupillometry was measured once during the follow-up and the pupil diameter change (PDC) was calculated as the millimeters difference between scotopic and photopic diameter. Results: After 24 months, group A and B did not differ significantly in SE, AL and PDC change (p > 0.05). In group A and B the SE change was positively correlated with PDC (p < 0.05), while AL change and PDC did not show significant correlation in both groups (p > 0.05). For group A and B the PDC median was respectively 4.5 and 4.7mm.Conclusion: These findings suggest that AL change could be considered not dependent by pupil dynamics for evaluating myopia progression, and that a PDC lower than 4.5mm seems to improve the effectiveness of peripheral defocus spectacle lenses in slowing SE increase in European Caucasian pediatric patients, without significant differences between DIMS and HALT design.
- Open Access
- 13 March 2025
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 11, 1480111
Case report: Clinical and genetic features of pediatric choroidal melanoma
Uveal melanoma (UM) is the second most common type of primary melanoma in adults, but it is extremely rare in children. We report a 12-year-old boy with a rare juvenile case of UM characterized by specific clinical and genetic features, including eye imaging and cytogenetic analysis. The tumor was analyzed using immunohistochemistry in order to confirm the clinical diagnosis and using next-generation sequencing (NGS) in order to investigate the correlation between pathological features and prognosis. The NGS revealed a somatic mutation in the GNAQ gene. Furthermore, we established a primary cell line (Opbg-UM1) to better understand the biology of this tumor in the pediatric setting. However, our case identified several factors predictive of poor prognosis, such as tumor proximity to the fovea and optic disc, large size, lack of pigmentation with mushroom configuration in category T2, and a complex karyotype showing numerical abnormalities on chromosome 6 and a mosaic loss of the Y chromosome in blood and in the primary cell line. This mutation may represent a poor prognostic factor in older children with UM.
- 13 March 2025
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 11, 1480111
Open AccessCase report: Clinical and genetic features of pediatric choroidal melanoma
Uveal melanoma (UM) is the second most common type of primary melanoma in adults, but it is extremely rare in children. We report a 12-year-old boy with a rare juvenile case of UM characterized by specific clinical and genetic features, including eye imaging and cytogenetic analysis. The tumor was analyzed using immunohistochemistry in order to confirm the clinical diagnosis and using next-generation sequencing (NGS) in order to investigate the correlation between pathological features and prognosis. The NGS revealed a somatic mutation in the GNAQ gene. Furthermore, we established a primary cell line (Opbg-UM1) to better understand the biology of this tumor in the pediatric setting. However, our case identified several factors predictive of poor prognosis, such as tumor proximity to the fovea and optic disc, large size, lack of pigmentation with mushroom configuration in category T2, and a complex karyotype showing numerical abnormalities on chromosome 6 and a mosaic loss of the Y chromosome in blood and in the primary cell line. This mutation may represent a poor prognostic factor in older children with UM.
- Open Access
Effectiveness of Defocus Incorporated Multiple Segments in Slowing Myopia Progression in Pediatric Patients as a Function of Age: Three-Year Follow-Up
Background: The purpose of this study is to evaluate the effectiveness of Defocus Incorporated Multiple Segments (DIMSs) in slowing myopia progression in pediatric patients as a function of age. Methods: This was a non-randomized experimenter-masked retrospective controlled observational study of European individuals aged 6–16 years with progressive myopia but no ocular pathology. We retrospectively reviewed the charts of the participants allocated to receive DIMS spectacles (Hoya® MiyoSmart®) or single-vision spectacle lenses (control group). Cycloplegic spherical equivalent (SE) and axial length (AL) were measured at baseline and at 12-, 24-, and 36-month follow-ups. The results were stratified by age into four groups: patients wearing DIMS spectacles older or younger than 10 years of age (group A, 20 patients mean age 13.6 ± 2.2, and group C, 20 patients mean age 9.0 ± 1.2) and age-matched control groups (group B, 18 patients mean age 13.2 ± 2.5, and group D, 22 patients mean age 8.5 ± 0.9). Results: At 36 months, SE and AL increase were significantly reduced in groups A and C, respectively, compared to groups B and D (p < 0.05). Linear regression analysis showed a significant correlation (p < 0.05) between patient age and myopia progression for SE in groups A and C, but only in group A for AL. Groups B and D did not show any significant correlation (p > 0.05). Conclusions: DIMS spectacles seem to slow myopia progression in pediatric patients; however, their effectiveness shows the greatest results in children older than 10 years of age. Moreover, our findings suggest that AL may be the more reliable parameter for evaluating myopia progression.
Open AccessEffectiveness of Defocus Incorporated Multiple Segments in Slowing Myopia Progression in Pediatric Patients as a Function of Age: Three-Year Follow-Up
Background: The purpose of this study is to evaluate the effectiveness of Defocus Incorporated Multiple Segments (DIMSs) in slowing myopia progression in pediatric patients as a function of age. Methods: This was a non-randomized experimenter-masked retrospective controlled observational study of European individuals aged 6–16 years with progressive myopia but no ocular pathology. We retrospectively reviewed the charts of the participants allocated to receive DIMS spectacles (Hoya® MiyoSmart®) or single-vision spectacle lenses (control group). Cycloplegic spherical equivalent (SE) and axial length (AL) were measured at baseline and at 12-, 24-, and 36-month follow-ups. The results were stratified by age into four groups: patients wearing DIMS spectacles older or younger than 10 years of age (group A, 20 patients mean age 13.6 ± 2.2, and group C, 20 patients mean age 9.0 ± 1.2) and age-matched control groups (group B, 18 patients mean age 13.2 ± 2.5, and group D, 22 patients mean age 8.5 ± 0.9). Results: At 36 months, SE and AL increase were significantly reduced in groups A and C, respectively, compared to groups B and D (p < 0.05). Linear regression analysis showed a significant correlation (p < 0.05) between patient age and myopia progression for SE in groups A and C, but only in group A for AL. Groups B and D did not show any significant correlation (p > 0.05). Conclusions: DIMS spectacles seem to slow myopia progression in pediatric patients; however, their effectiveness shows the greatest results in children older than 10 years of age. Moreover, our findings suggest that AL may be the more reliable parameter for evaluating myopia progression.
- Open Access
- 13 August 2024
- Published by MDPI AG in Preprints.org
Effectiveness of Defocus Incorporated Multiple Segments in Slowing Myopia Progression in Pediatric Patients as a Function of the Age. Three Years Follow Up
Background: To evaluate the effectiveness of Defocus Incorporated Multiple Segments (DIMS) in slowing myopia progression in pediatric patients as a function of age. Methods: This was a non-randomized experimenter-masked retrospective controlled observational study of European individuals aged 6 -16 years with progressive myopia but no ocular pathology. We retrospectively reviewed the charts of the participants allocated to receive DIMS spectacles (Hoya® MiyoSmart®) or single vision spectacle lenses (control group). Cycloplegic spherical equivalent (SE) and axial length (AL), were measured at baseline and at 36 month follow up. The results were stratified by age into four groups: patients that wore DIMS spectacles oldest or youngest than 10 years of age (respectively, group A, 20 patients mean age 13.6±2.2 and group C, 20 patients mean age 9.0±1.2) and age-matched control groups (group B, 18 patients mean age 13.2±2.5 and group D, 22 patients mean age 8.5±0.9). Results: At 36 months, SE and AL increase resulted significantly reduced in groups A and C, respectively compared to groups B and D (p<0.05). Linear regression analysis showed a significant correlation (P0.05). Conclusion: DIMS spectacles seem to slow myopia increase in pediatric patients, however their effectiveness results greatest in children oldest than 10 years of age. Morover our findings suggest that AL may be the more reliable parameter for evaluating myopia progression.
- 13 August 2024
- Published by MDPI AG in Preprints.org
Open AccessEffectiveness of Defocus Incorporated Multiple Segments in Slowing Myopia Progression in Pediatric Patients as a Function of the Age. Three Years Follow Up
Background: To evaluate the effectiveness of Defocus Incorporated Multiple Segments (DIMS) in slowing myopia progression in pediatric patients as a function of age. Methods: This was a non-randomized experimenter-masked retrospective controlled observational study of European individuals aged 6 -16 years with progressive myopia but no ocular pathology. We retrospectively reviewed the charts of the participants allocated to receive DIMS spectacles (Hoya® MiyoSmart®) or single vision spectacle lenses (control group). Cycloplegic spherical equivalent (SE) and axial length (AL), were measured at baseline and at 36 month follow up. The results were stratified by age into four groups: patients that wore DIMS spectacles oldest or youngest than 10 years of age (respectively, group A, 20 patients mean age 13.6±2.2 and group C, 20 patients mean age 9.0±1.2) and age-matched control groups (group B, 18 patients mean age 13.2±2.5 and group D, 22 patients mean age 8.5±0.9). Results: At 36 months, SE and AL increase resulted significantly reduced in groups A and C, respectively compared to groups B and D (p<0.05). Linear regression analysis showed a significant correlation (P0.05). Conclusion: DIMS spectacles seem to slow myopia increase in pediatric patients, however their effectiveness results greatest in children oldest than 10 years of age. Morover our findings suggest that AL may be the more reliable parameter for evaluating myopia progression.
- 1 August 2020
- Published by Elsevier in Journal of American Association for Pediatric Ophthalmology and Strabismus
- Vol. 24 (4) , 212-215
Ocular manifestations and viral shedding in tears of pediatric patients with coronavirus disease 2019: a preliminary report
- 1 August 2020
- Published by Elsevier in Journal of American Association for Pediatric Ophthalmology and Strabismus
- Vol. 24 (4) , 212-215
Ocular manifestations and viral shedding in tears of pediatric patients with coronavirus disease 2019: a preliminary report
- Open Access
Proteomic Profiling of Retinoblastoma-Derived Exosomes Reveals Potential Biomarkers of Vitreous Seeding
Retinoblastoma (RB) is the most common tumor of the eye in early childhood. Although recent advances in conservative treatment have greatly improved the visual outcome, local tumor control remains difficult in the presence of massive vitreous seeding. Traditional biopsy has long been considered unsafe in RB, due to the risk of extraocular spread. Thus, the identification of new biomarkers is crucial to design safer diagnostic and more effective therapeutic approaches. Exosomes, membrane-derived nanovesicles that are secreted abundantly by aggressive tumor cells and that can be isolated from several biological fluids, represent an interesting alternative for the detection of tumor-associated biomarkers. In this study, we defined the protein signature of exosomes released by RB tumors (RBT) and vitreous seeding (RBVS) primary cell lines by high resolution mass spectrometry. A total of 5666 proteins were identified. Among these, 5223 and 3637 were expressed in exosomes RBT and one RBVS group, respectively. Gene enrichment analysis of exclusively and differentially expressed proteins and network analysis identified in RBVS exosomes upregulated proteins specifically related to invasion and metastasis, such as proteins involved in extracellular matrix (ECM) remodeling and interaction, resistance to anoikis and the metabolism/catabolism of glucose and amino acids.
Open AccessProteomic Profiling of Retinoblastoma-Derived Exosomes Reveals Potential Biomarkers of Vitreous Seeding
Retinoblastoma (RB) is the most common tumor of the eye in early childhood. Although recent advances in conservative treatment have greatly improved the visual outcome, local tumor control remains difficult in the presence of massive vitreous seeding. Traditional biopsy has long been considered unsafe in RB, due to the risk of extraocular spread. Thus, the identification of new biomarkers is crucial to design safer diagnostic and more effective therapeutic approaches. Exosomes, membrane-derived nanovesicles that are secreted abundantly by aggressive tumor cells and that can be isolated from several biological fluids, represent an interesting alternative for the detection of tumor-associated biomarkers. In this study, we defined the protein signature of exosomes released by RB tumors (RBT) and vitreous seeding (RBVS) primary cell lines by high resolution mass spectrometry. A total of 5666 proteins were identified. Among these, 5223 and 3637 were expressed in exosomes RBT and one RBVS group, respectively. Gene enrichment analysis of exclusively and differentially expressed proteins and network analysis identified in RBVS exosomes upregulated proteins specifically related to invasion and metastasis, such as proteins involved in extracellular matrix (ECM) remodeling and interaction, resistance to anoikis and the metabolism/catabolism of glucose and amino acids.
- Open Access
- 4 November 2015
- Published by Springer Nature in BMC Cancer
- Vol. 15 (1) , 841
Advantages of a next generation sequencing targeted approach for the molecular diagnosis of retinoblastoma
Retinoblastoma (RB) is the most common malignant childhood tumor of the eye and results from inactivation of both alleles of the RB1 gene. Nowadays RB genetic diagnosis requires classical chromosome investigations, Multiplex Ligation-dependent Probe Amplification analysis (MLPA) and Sanger sequencing. Nevertheless, these techniques show some limitations. We report our experience on a cohort of RB patients using a combined approach of Next-Generation Sequencing (NGS) and RB1 custom array-Comparative Genomic Hybridization (aCGH). A total of 65 patients with retinoblastoma were studied: 29 cases of bilateral RB and 36 cases of unilateral RB. All patients were previously tested with conventional cytogenetics and MLPA techniques. Fifty-three samples were then analysed using NGS. Eleven cases were analysed by RB1 custom aCGH. One last case was studied only by classic cytogenetics. Finally, it has been tested, in a lab sensitivity assay, the capability of NGS to detect artificial mosaicism series in previously recognized samples prepared at 3 different mosaicism frequencies: 10, 5, 1 %. Of the 29 cases of bilateral RB, 28 resulted positive (96.5 %) to the genetic investigation: 22 point mutations and 6 genomic rearrangements (four intragenic and two macrodeletion). A novel germline intragenic duplication, from exon18 to exon 23, was identified in a proband with bilateral RB. Of the 36 available cases of unilateral RB, 8 patients resulted positive (22 %) to the genetic investigation: 3 patients showed point mutations while 5 carried large deletion. Finally, we successfully validated, in a lab sensitivity assay, the capability of NGS to accurately measure level of artificial mosaicism down to 1 %. NGS and RB1-custom aCGH have demonstrated to be an effective combined approach in order to optimize the overall diagnostic procedures of RB. Custom aCGH is able to accurately detect genomic rearrangements allowing the characterization of their extension. NGS is extremely accurate in detecting single nucleotide variants, relatively simple to perform, cost savings and efficient and has confirmed a high sensitivity and accuracy in identifying low levels of artificial mosaicisms.
- 4 November 2015
- Published by Springer Nature in BMC Cancer
- Vol. 15 (1) , 841
Open AccessAdvantages of a next generation sequencing targeted approach for the molecular diagnosis of retinoblastoma
Retinoblastoma (RB) is the most common malignant childhood tumor of the eye and results from inactivation of both alleles of the RB1 gene. Nowadays RB genetic diagnosis requires classical chromosome investigations, Multiplex Ligation-dependent Probe Amplification analysis (MLPA) and Sanger sequencing. Nevertheless, these techniques show some limitations. We report our experience on a cohort of RB patients using a combined approach of Next-Generation Sequencing (NGS) and RB1 custom array-Comparative Genomic Hybridization (aCGH). A total of 65 patients with retinoblastoma were studied: 29 cases of bilateral RB and 36 cases of unilateral RB. All patients were previously tested with conventional cytogenetics and MLPA techniques. Fifty-three samples were then analysed using NGS. Eleven cases were analysed by RB1 custom aCGH. One last case was studied only by classic cytogenetics. Finally, it has been tested, in a lab sensitivity assay, the capability of NGS to detect artificial mosaicism series in previously recognized samples prepared at 3 different mosaicism frequencies: 10, 5, 1 %. Of the 29 cases of bilateral RB, 28 resulted positive (96.5 %) to the genetic investigation: 22 point mutations and 6 genomic rearrangements (four intragenic and two macrodeletion). A novel germline intragenic duplication, from exon18 to exon 23, was identified in a proband with bilateral RB. Of the 36 available cases of unilateral RB, 8 patients resulted positive (22 %) to the genetic investigation: 3 patients showed point mutations while 5 carried large deletion. Finally, we successfully validated, in a lab sensitivity assay, the capability of NGS to accurately measure level of artificial mosaicism down to 1 %. NGS and RB1-custom aCGH have demonstrated to be an effective combined approach in order to optimize the overall diagnostic procedures of RB. Custom aCGH is able to accurately detect genomic rearrangements allowing the characterization of their extension. NGS is extremely accurate in detecting single nucleotide variants, relatively simple to perform, cost savings and efficient and has confirmed a high sensitivity and accuracy in identifying low levels of artificial mosaicisms.
- 14 July 2015
- Published by Wiley in Pediatric Blood & Cancer
- Vol. 62 (12) , 2245-2246
Sporadic Retinoblastoma and Pilocytic Astrocytoma: A Rare Association of Two Tumors
- 14 July 2015
- Published by Wiley in Pediatric Blood & Cancer
- Vol. 62 (12) , 2245-2246
Sporadic Retinoblastoma and Pilocytic Astrocytoma: A Rare Association of Two Tumors
- 1 December 2014
- Vol. 34 (12) , 7449-54
Baseline central nervous system magnetic resonance imaging in early detection of trilateral retinoblastoma: pitfalls in the diagnosis of pineal gland lesions.
Trilateral retinoblastoma (TRB) is a rare disease associating bilateral retinoblastoma (RB) with primitive intracranial neuroblastic tumor. To verify the occurrence of TRB in a single-Center case series and point out the clinical relevance of a baseline brain magnetic resonance imaging (MRI) in RB, focusing on pineal gland lesions. Baseline MRI was routinely performed in all cases of RB from 1999. All MRIs were reviewed for this study and the RB database was checked in order to identify patients characteristics, treatments and follow-up. A total of 107 patients with RB were diagnosed between 1999 and 2012. Sixty-two patients had unilateral RB and 45 bilateral RB. MRI revealed the presence of pineal gland lesions in 10 patients (9%); seven were considered pineal benign cysts (6.5%), while in three patients (2.8%), TRB was suspected. All patients with TRB presented hereditary RB. In one patient, the suspected TRB was metachronous and in the other two patients was synchronous. Biopsy was not performed. Cerobrospinal fluid (CSF) was negative in all patients. The MRI modification, before treatment in the first case and later in the second case, confirmed the TRB diagnosis. The third patient died due to progressive Central Nervous System (CNS) disease that clearly confirmed the TRB diagnosis. None of the three patients had received prior chemotherapeutic treatment. TRB represents a rare condition in this series, occurring in three (2.8%) out of all patients with RB. A synchronous presentation with small lesion seems more frequent when a baseline MRI is performed. When a histologically-proven diagnosis is not available, a suspected diagnosis should be considered with caution and only follow-up will confirm the diagnosis. A wait-and-see approach should be considered.
- 1 December 2014
- Vol. 34 (12) , 7449-54
Baseline central nervous system magnetic resonance imaging in early detection of trilateral retinoblastoma: pitfalls in the diagnosis of pineal gland lesions.
Trilateral retinoblastoma (TRB) is a rare disease associating bilateral retinoblastoma (RB) with primitive intracranial neuroblastic tumor. To verify the occurrence of TRB in a single-Center case series and point out the clinical relevance of a baseline brain magnetic resonance imaging (MRI) in RB, focusing on pineal gland lesions. Baseline MRI was routinely performed in all cases of RB from 1999. All MRIs were reviewed for this study and the RB database was checked in order to identify patients characteristics, treatments and follow-up. A total of 107 patients with RB were diagnosed between 1999 and 2012. Sixty-two patients had unilateral RB and 45 bilateral RB. MRI revealed the presence of pineal gland lesions in 10 patients (9%); seven were considered pineal benign cysts (6.5%), while in three patients (2.8%), TRB was suspected. All patients with TRB presented hereditary RB. In one patient, the suspected TRB was metachronous and in the other two patients was synchronous. Biopsy was not performed. Cerobrospinal fluid (CSF) was negative in all patients. The MRI modification, before treatment in the first case and later in the second case, confirmed the TRB diagnosis. The third patient died due to progressive Central Nervous System (CNS) disease that clearly confirmed the TRB diagnosis. None of the three patients had received prior chemotherapeutic treatment. TRB represents a rare condition in this series, occurring in three (2.8%) out of all patients with RB. A synchronous presentation with small lesion seems more frequent when a baseline MRI is performed. When a histologically-proven diagnosis is not available, a suspected diagnosis should be considered with caution and only follow-up will confirm the diagnosis. A wait-and-see approach should be considered.
- 1 March 2014
- Published by Elsevier in The Journal of Pediatrics
- Vol. 164 (3) , 670
Corneal Arcus as First Sign of Familial Hypercholesterolemia
- 1 March 2014
- Published by Elsevier in The Journal of Pediatrics
- Vol. 164 (3) , 670
Corneal Arcus as First Sign of Familial Hypercholesterolemia